Thrombolytic treatment (alteplase; rt-PA) in acute massive pulmonary embolism and cardiopulmonary arrest

Drug Design, Development and Therapy

Volumn 8, Issue , 2014, Pages 759-763

  Dirican, Adem ^a   Ozkaya, Sevket ^b   Atas, Ali Ekber ^a   Ulu, Esra Kayahan ^a   Kitapci, Ilknur ^a   Ece, Ferah ^b  

^a Department of Cardiac Surgery   (Turkey)

^b BAHCESEHIR UNIVERSITY   (Turkey)

Author keywords

Cardiopulmonary arrest; Hemorrhage; Massive pulmonary embolism; Mortality; Resuscitation; Rt PA; Thrombolytic treatment

Indexed keywords

ALTEPLASE; TISSUE PLASMINOGEN ACTIVATOR;

ADULT; AGED; ALLERGIC REACTION; ARTICLE; BLEEDING; CARDIOPULMONARY ARREST; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTINUOUS INFUSION; CONTRAST ENHANCEMENT; DRUG FATALITY; DRUG SAFETY; DYSPNEA; ECHOCARDIOGRAPHY; FAINTNESS; FEMALE; FIBRINOLYTIC THERAPY; HUMAN; HYPOTENSION; HYPOXIA; LUNG EMBOLISM; MALE; MIDDLE AGED; MORTALITY; RESUSCITATION; SURVIVAL RATE; TACHYCARDIA; TURKEY (REPUBLIC); VERY ELDERLY; ACUTE DISEASE; HEART ARREST; METABOLISM; PULMONARY EMBOLISM; RETROSPECTIVE STUDY;

ACUTE DISEASE; ADULT; AGED; AGED, 80 AND OVER; FEMALE; HEART ARREST; HUMANS; MALE; MIDDLE AGED; PULMONARY EMBOLISM; RETROSPECTIVE STUDIES; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR;

EID: 84902519861     PISSN: 11778881     EISSN: None     Source Type: Journal    
DOI: 10.2147/DDDT.S61679     Document Type: Article

References (18)

1. Horlander KT, Mannino DM, Leeper K V. Pulmonary embolism mortality in the United States, 1979-1998: an analysis using multiple-cause mortality data. Arch Intern Med. 2003;163(14):1711-1717.
2. Burge AJ, Freeman KD, Klapper PJ, Haramati LB. Increased diagnosis of pulmonary embolism without a corresponding decline in mortality during the CT era. Clin Radiol. 2008;63(4):381-386.
3. Kearon C, Kahn SR, Agnelli G, Goldhaber S, Raskob GE, Comerota AJ; American College of Chest Physicians. Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest. 2 008; 133(Suppl 6):454S-545S.
4. Darze ES, Latado AL, Guimarães AG, et al. Incidence and clinical predictors of pulmonary embolism in severe heart failure patients admitted to a coronary care unit. Chest. 2005;128(4):2576-2580.
5. Goldhaber SZ, Visani L, De Rosa M. Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER). Lancet. 1999;353(9162):1386-1389.
6. Kucher N, Goldhaber SZ. Management of massive pulmonary embolism. Circulation. 2005;112(2):e28-e32.
7. Stein PD, Hull RD, Ghali WA, et al. Tracking the uptake of evidence: two decades of hospital practice trends for diagnosing deep vein thrombosis and pulmonary embolism. Arch Intern Med. 2003;163(10): 1213-1219.
8. Sors H, Pacouret G, Azarian R, Meyer G, Charbonnier B, Simonneau G. Hemodynamic effects of bolus vs 2-h Infusion of alteplase in acute massive pulmonary embolism. A randomized controlled multicenter trial. Chest. 1994;106(3):712-717.
9. Torbicki A, Galié N, Covezzoli A, Rossi E, De Rosa M, Goldhaber SZ; ICOPER Study Group. Right heart thrombi in pulmonary embolism: results from the International Cooperative Pulmonary Embolism Registry. J Am Coll Cardiol. 2003;41(12):2245-2251.
10. Pruszczyk P, Torbicki A, Kuch-Wocial A, Szulc M, Pacho R. Diagnostic value of transoesophageal echocardiography in suspected haemodynamically signifcant pulmonary embolism. Heart. 2001;85(6):628-634.
11. Schoepf UJ, Kucher N, Kipfmueller F, Quiroz R, Costello P, Goldhaber SZ. Right ventricular enlargement on chest computed tomography: a predictor of early death in acute pulmonary embolism. Circulation. 2004;110(20):3276-3280.
12. Wan S, Quinlan DJ, Agnelli G, Eikelboom J W. Thrombolysis compared with heparin for the initial treatment of pulmonary embolism: a meta-analysis of the randomized controlled trials. Circulation. 2004;110(6):744-749.
13. Büller HR, Agnelli G, Hull RD, Hyers TM, Prins MH, Raskob GE. Antithrombotic therapy for venous thromboembolic disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004;126(Suppl 3):401S-428S.
14. Silfvast T. Cause of death in unsuccessful prehospital resuscitation. J Intern Med. 1991;229(4):331-335.
15. Spaulding CM, Joly LM, Rosenberg A, et al. Immediate coronary angiography in survivors of out-of-hospital cardiac arrest. N Engl J Med. 1997;336(23):1629-1633.
16. Indications for fbrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Fibrinolytic Therapy Trialists' (FTT) Collaborative Group. Lancet. 1994;34(8893):311-322.
17. Arcasoy SM, Kreit J W. Thrombolytic therapy of pulmonary embolism: a comprehensive review of current evidence. Chest. 1999;115(6): 1695-1707.
18. Ruiz-Bailén M, Aguayo-de-Hoyos E, Serrano-Córcoles MC, et al. Thrombolysis with recombinant tissue plasminogen activator during cardiopulmonary resuscitation in fulminant pulmonary embolism. A case series. Resuscitation. 2001;51(1):97-101.